VALBAZEN DIN 01904779
Health Canada record
| Active ingredient(s) | ALBENDAZOLE 113.6 MG |
|---|---|
| Dosage form | Suspension |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1990 |
| Current status date | 28-Jul-2016 |
| Source | Health Canada DPD |
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 15310 | 2014-02-24 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBER (DIN) HOLDER |
| 6961 | 1998-12-18 | New Drug Submission (NDS) |
International API supply for ALBENDAZOLE
4 valid EDQM Certificates of Suitability from 4 holders. 10 active FDA Drug Master Files.
Special Access Programme
This molecule appears on Health Canada's list of drugs most often requested through the Special Access Programme.
Request a quote for VALBAZEN